Johnson & Johnson lost a $5.7 million verdict on Thursday in the first test case over one of its newest pelvic mesh slings, which is among dozens of similar devices named in thousands of lawsuits across the country.
The verdict, by a jury in Bakersfield, Calif., is the latest to hit Johnson & Johnson, whose Ethicon Inc. subsidiary has lost verdicts over its other mesh devices. The trial, which began on Jan. 26, was the first over Ethicon’s TVT-Abbrevo device, which is used to treat urinary incontinence caused from sudden movements. The plaintiff, Coleen Perry, had alleged that she had pain and continued urinary problems after having the device implanted in 2011.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
